|
1
|
Mohan A and Ponnusankar S: Newer Therapies
for the Treatment of Metastatic Breast Cancer: a Clinical Update.
Indian J Pharm Sci. 75:251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lucci A, Hall CS, Lodhi AK, et al:
Circulating tumour cells in non-metastatic breast cancer: a
prospective study. Lancet Oncol. 13:688–695. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Valente SA, Levine GM, Silverstein MJ, et
al: Accuracy of predicting axillary lymph node positivity by
physical examination, mammography, ultrasonography, and magnetic
resonance imaging. Ann Surg Oncol. 19:1825–1830. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scaranelo AM, Eiada R, Jacks LM, Kulkarni
SR and Crystal P: Accuracy of unenhanced MR imaging in the
detection of axillary lymph node metastasis: study of
reproducibility and reliability. Radiology. 262:425–434. 2012.
View Article : Google Scholar
|
|
5
|
Hung T, Piris A, Lobo A, et al: Sentinel
lymph node metastasis is not predictive of poor outcome in patients
with problematic spitzoid melanocytic tumors. Hum Pathol. 44:87–94.
2013. View Article : Google Scholar
|
|
6
|
McMasters M, Tuttle M, Carlson J, et al:
Sentinel lymph node biopsy for breast cancer: A suitable
alternative to routine axillary dissection in multi-institutional
practice when optimal technique is used. J Clin Oncol.
18:2560–2566. 2000.PubMed/NCBI
|
|
7
|
Clough KB, Nasr R, Nos C, Vieira M,
Inguenault C and Poulet B: New anatomical classification of the
axilla with implications for sentinel node biopsy. Br J Surg.
97:1659–1665. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schwartz GF, Guiliano AE and Veronesi U;
Consensus Conference Committee. Proceeding of the consensus
conference of the role of sentinel lymph node biopsy in carcinoma
or the breast; April 19–22, 2001; Philadelphia, PA, USA. Breast J.
8. pp. 124–138. 2002
|
|
9
|
Krag DN, Anderon SJ, Julian TB, et al:
Sentinel-lymph-node resection compared with conventional
axillary-lymph-node dissection in clinically node-negative patients
with breast cancer: overall survival findings from the NSABP B-32
randomised phase 3 trial. Lancet Oncol. 11:927–933. 2011.
View Article : Google Scholar :
|
|
10
|
Goyal A, Newcombe RG, Chhabra A and Mansel
RE; ALMANAC Trialists Group. Factors affecting failed localisation
and false-negative rates of sentinel node biopsy in breast
cancer–results of the ALMANAC validation phase. Breast Cancer Res
Trea. 99:203–208. 2006. View Article : Google Scholar
|
|
11
|
Mátrai Z, Tóth L, Saeki T, et al: The
potential role of SPECT/CT in the preoperative detection of
sentinel lymph nodes in breast cancer. Orv Hetil. 152:678–688.
2011. View Article : Google Scholar
|
|
12
|
Pesek S, Ashikaga T, Krag LE and Krag D:
The false-negative rate of sentinel node biopsy in patients with
breast cancer: a meta-analysis. World J Surg. 36:2239–2251. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shimazu K, Tamaki Y, Taguchi T, Takamura Y
and Noguchi S: Comparison between periareolar and peritumoral
injection of radiotracer for sentinel lymph node biopsy in patients
with breast cancer. Surgery. 131:277–286. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Borgstein PJ, Meijer S, Pijpers RJ and van
Diest PJ: Functional lymphatic anatomy for sentinel node biopsy in
breast cancer: echoes from the past and the periareolar blue
method. Ann Surg. 232:81–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ogasawara Y, Yoshitomi S, Sato S and
Doihara H: Clinical significance of preoperative lymphoscintigraphy
for sentinel lymph node biopsy in breast cancer. J Surg Res.
148:191–196. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sabaté-Llobera A, Benítez-Segura A, Marí
A, et al: Lymphoscintigraphy in oral squamous cell carcinoma
sentinel node biopsy and its role in the surgical planning. Clin
Nucl Med. 39:e142–e145. 2014.
|
|
17
|
Noguchi M: Sentinel lymph node biopsy as
an alternative to routine axillary lymph node dissection in breast
cancer patients. J Surg Oncol. 76:144–156. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Uren RF, Howman-Giles R, Renwick SB and
Gillett D: Lymphatic mapping of the breast: locating the sentinel
lymph nodes. World J Surg. 25:789–793. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kraft O and Havel M: Sentinel lymph nodes
and planar scintigraphy and SPECT/CT in various types of tumours.
Estimation of some factors influencing detection success. Nucl Med
Rev Cent East Eur. 16:17–25. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martínez-Rodríguez I, De Arcocha Torres M,
Banzo I, et al: Evaluation of the contribution of the dynamic phase
of lymphoscintigraphy to the detection of sentinel lymph node in
breast cancer. Q J Nucl Med Mol Imaging. 57:296–300.
2013.PubMed/NCBI
|
|
21
|
Brouwer OR, Vermeeren L, van der Ploeg IM,
et al: Lymphoscintigraphy and SPECT/CT in multicentric and
multifocal breast cancer: does each tumour have a separate drainage
pattern? Results of a Dutch multicentre study (MULTISENT). Eur J
Nucl Med Mol Imaging. 39:1137–1143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nelson KP, Choudhury KR, Coleman RE,
Shipes SW, Siler WL, Hubble WL and Wong TZ: Does the preparation
and utilization of 99mTc-sulfur colloid affect the
outcomes of breast lymphoscintigraphy? J Nucl Med Technol.
41:92–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yeung HW, Cody HS III, Turlakow A, et al:
Lymphoscintigraphy and sentinel node localization in breast cancer
patients: A comparison between 1-day and 2-day protocols. J Nucl
Med. 42:420–423. 2001.PubMed/NCBI
|
|
24
|
Tanis PJ, van Sandick JW, Nieweg OE,
Valdés Olmos RA, Rutgers EJ, Hoefnagel CA and Kroon BB: The hidden
sentinel node in breast cancer. Eur J Nucl Med. 29:305–310. 2002.
View Article : Google Scholar
|
